Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ELCC 2023 | ctDNA approaches in lung cancer

Umberto Malapelle • 27 Mar 2023
ELCC 2023
Lung Cancer Non-Small Cell Lung Cancer

Umberto Malapelle, PhD, University of Naples Federico II, Naples, Italy, discusses ctDNA-based approaches in the clinical management of lung cancer, including molecular profiling, as well as monitoring of minimal residual disease. This interview took place at the European Lung Cancer Congress 2023 in Copenhagen, Denmark.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Umberto Malapelle

0:54
Liquid biopsy highlights from ELCC 2023
Umberto Malapelle • 27 Mar 2023
1:23
Optimal positioning of liquid biopsies in the workup of patients with NSCLC
Umberto Malapelle • 27 Mar 2023
1:57
Potential of liquid biopsy in lung cancer
Umberto Malapelle • 18 Oct 2022
1:36
Unmet needs in liquid biopsy research
Umberto Malapelle • 18 Oct 2022

Related Videos

2:38
Phase I trial of binimetinib and pembrolizumab in NSCLC
Natasha Leighl • 17 Apr 2024
2:43
CHRYSALIS: amivantamab in wild-type, pre-treated NSCLC
Natasha Leighl • 17 Apr 2024
3:03
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
Sanjay Popat • 19 Apr 2024
2:09
Is there a role for radiotherapy in extensive-stage SCLC?
Clive Peedell • 18 Apr 2024
The content of VJOncology is intended for healthcare professionals